This is a non-core endpoint: only basic statistics are computed.
See its core counterpart C3_KIDNEY_NOTRENALPELVIS_EXALLC for full statistics.
Malignant neoplasm of kidney, except renal pelvis
C3_KIDNEY_NOTRENALPELVIS
kidney neoplasm: A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
3414 |
4. Check minimum number of eventsNone |
3414 |
5. Include endpoints |
3414 |
6. Filter based on genotype QC (FinnGen only) |
3414 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF9
Similar endpoints
↥List of similar endpoints to
Malignant neoplasm of kidney, except renal pelvis
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm of urinary organs
- Malignant neoplasm of kidney, except renal pelvis, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm of urinary organs, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 3414 | 1230 | 2184 |
| Unadjusted period prevalence (%) | 0.77 | 0.42 | 0.96 |
| Median age at first event (years) | 66.29 | 65.45 | 66.76 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 3137
- Matched controls
- 31366
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
1413
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
323.0
1013
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
323.0
325
*
JN4AD
NOMESCO Finland
Body CT examination
8.0
323.0
825
1345
C64
ICD-10 Finland
Malignant neoplasm of kidney, except renal pelvis
2953.5
323.0
729
*
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
306.0
323.0
377
14
KAC10
NOMESCO Finland
Total nephrectomy with capsule
740.8
323.0
826
15
197
Kela drug reimbursment
Sunitinib
537.6
323.0
338
7
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
4715.2
323.0
2811
53
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
449.0
323.0
621
17
KAD00
NOMESCO Finland
Partial nephrectomy
388.2
323.0
402
12
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
261.3
323.0
1990
207
B01AB10
ATC
tinzaparin; parenteral
8.4
301.3
733
1104
L01XE04
ATC
[U] sunitinib; oral
1010.3
286.9
277
*
130
Kela drug reimbursment
Malignant tumour
6.2
263.3
806
1654
KA3AT
NOMESCO Finland
Biopsy of kidney with ultrasound guidance
33.1
262.4
349
118
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
5.0
241.9
921
2411
WX302
NOMESCO Finland
Thoracal epidural anesthesy
8.4
226.3
536
748
JN4CD
NOMESCO Finland
Very extensive body CT
9.2
220.6
493
623
JN4BD
NOMESCO Finland
Extensive body CT
4.7
210.0
829
2210
1502
Kela drug reimbursment
Cabozantinib
1020.4
198.1
192
*
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
6.7
197.4
549
960
3012
Kela drug reimbursment
Cabozantinib
975.1
189.6
184
*
KAC00
NOMESCO Finland
Nephrectomy
113.5
186.6
202
19
C64.80
ICD-10 Finland
Wilms tumour
385.1
183.6
183
5
TPH07
NOMESCO Finland
Cathetrisation of artery
4.5
183.2
748
2030
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
30.9
176.2
238
83
159
Kela drug reimbursment
Pazopanib
863.0
168.4
164
*
U75
ICPC
Malignant neoplasm of kidney
177.3
161.3
168
10
8317/3-C64.9
ICD-O-3
Renal cell carcinoma, chromophobe type of kidney, NOS
+∞
159.7
152
*
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
14.7
153.1
265
195
7125
FHL
Nephrectomy (extrrafascial)
1559.3
151.2
146
*
WX408
NOMESCO Finland
General anesthesy, balanced
2.9
144.9
1205
5569
322
Kela drug reimbursment
Sunitinib
670.3
131.5
129
*
L01XE26
ATC
[U] cabozantinib; oral
+∞
129.0
123
*
B01AB05
ATC
enoxaparin; parenteral
2.6
122.4
1310
6852
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
7.1
119.2
310
478
L01XE11
ATC
[U] pazopanib; oral
599.9
117.9
116
*
8000/3-C64.9
ICD-O-3
Neoplasm, malignant of kidney, NOS
+∞
113.2
108
*
1890B
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,ADENOCARCINOMA]
+∞
111.1
106
*
N02AX02
ATC
tramadol; systemic, rectal
2.3
106.6
1631
10024
L01EX07
ATC
cabozantinib; oral
535.3
105.3
104
*
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.3
102.4
1714
10906
158
Kela drug reimbursment
Everolimus
513.9
101.1
100
*
180
Kela drug reimbursment
Interferon alfa
40.3
98.1
124
32
KA1AE
NOMESCO Finland
Kidney ultrasound examination
7.2
91.8
235
351
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
3.6
82.2
406
1233
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
5.2
80.9
268
555
WX402
NOMESCO Finland
General anaesthesia
2.7
79.4
645
2760
WF049
NOMESCO Finland
Radiotherapy of metastasis
5.3
76.0
246
495
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
5.0
75.0
258
556
168
Kela drug reimbursment
Axitinib
+∞
74.2
71
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.3
73.2
402
1321
KA3LT
NOMESCO Finland
Njurlesion coagulation
90.0
71.2
79
9
WZC30
NOMESCO Finland
Teaching
2.6
69.2
569
2431
D30.0
ICD-10 Finland
Benign neoplasm: Kidney
16.2
67.5
111
71
A03FA01
ATC
metoclopramide; systemic, rectal
2.3
66.3
755
3819
L01XE10
ATC
[U] everolimus; oral
318.1
62.6
63
*
N02AA05
ATC
oxycodone; systemic
2.4
61.9
645
3108
KAC01
NOMESCO Finland
Percutaneous endoscopic nephrectomy
128.5
59.0
63
5
R31
ICD-10 Finland
Unspecified haematuria
2.5
58.1
527
2355
1890X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,EI HIST VAHV]
578.3
57.8
57
*
343
Kela drug reimbursment
Pazopanib
+∞
57.5
55
*
U14
ICPC
Kidney symptom/complaint
8.6
57.4
128
154
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
56.5
1071
6627
C648
ICD-10 Finland
NA
+∞
56.4
54
*
N02BE01
ATC
paracetamol; systemic, rectal
2.2
56.1
2672
22816
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
6.2
55.9
157
265
L01XE17
ATC
[U] axitinib; oral
+∞
55.4
53
*
N18.8
ICD-10 Finland
Other chronic renal failure
4.4
51.7
197
469
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
9.8
48.5
100
105
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
3.0
47.9
298
1054
UKC02
NOMESCO Finland
Cystoscopy
2.0
47.5
716
4007
C08CA01
ATC
amlodipine; oral
1.8
46.6
1339
9358
L01EX01
ATC
sunitinib; oral
238.4
46.1
47
*
R4110
NOMESCO Finland
Physiotherapy
1.9
45.9
902
5561
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
4.9
45.6
155
328
8960/3-C64.9
ICD-O-3
Nephroblastoma, NOS, of kidney, NOS
+∞
44.9
43
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.9
44.4
754
4400
A11CC03
ATC
alfacalcidol; systemic
5.0
44.2
147
304
D41.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Renal pelvis
21.4
44.0
65
31
TK800
NOMESCO Finland
Hemodialysis
5.2
44.0
142
284
340
Kela drug reimbursment
Everolimus
433.3
43.3
43
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.3
42.2
425
1979
Z51.5
ICD-10 Finland
Palliative care
2.8
42.1
299
1150
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
4.9
41.3
139
291
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.5
40.0
333
1404
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
39.9
632
3575
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
4.8
39.9
138
298
XX3DW
NOMESCO Finland
Time consuming IT work
2.3
39.8
393
1810
361
Kela drug reimbursment
Axitinib
+∞
38.6
37
*
JN1CD
NOMESCO Finland
Very extensive CT examination of upper part of abdomen
9.5
37.9
79
85
C65
ICD-10 Finland
Malignant neoplasm of renal pelvis
19.0
36.6
56
30
WD515
NOMESCO Finland
Demanding therapy of malignancy with enzyme inhibitors and similar treatments
19.6
35.7
54
28
PHE70
NOMESCO Finland
Thrombectomy of inferior vena cava
+∞
35.5
34
*
M04AA01
ATC
allopurinol; systemic
1.9
34.5
557
3150
205
Kela drug reimbursment
Chronic hypertension
1.6
33.7
1103
7787
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.6
33.7
259
1039
1890A
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,NEPHROBLASTOMA]
+∞
33.4
32
*
V03AE01
ATC
polystyrene sulfonate; oral
6.0
32.6
92
157
198
Kela drug reimbursment
Sorafenib
18.4
31.8
49
27
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
7.5
31.6
76
104
GD1AD
NOMESCO Finland
Thorax CT examination
2.9
31.3
202
731
ZXA05
NOMESCO Finland
Left side
1.7
30.2
856
5768
KA4AT
NOMESCO Finland
Cytology of kidney with ultrasound guidance
58.9
30.1
35
6
JN1BD
NOMESCO Finland
Extensive CT examination of upper part of abdomen
9.4
29.8
62
67
KH1CD
NOMESCO Finland
Very extensive urinary tract ultrasound examination
5.6
29.7
88
160
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
9.8
29.6
60
62
A12AA04
ATC
calcium carbonate; oral
5.0
29.4
97
200
BCA30
NOMESCO Finland
Unilateral adrenalectomy
27.0
29.3
40
15
S18
ICPC
Laceration/cut
1.5
28.9
1318
9999
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.5
28.1
232
970
I10
ICD-10 Finland
Essential (primary) hypertension
1.5
27.9
1965
16406
18900
ICD-8 Finland
Malignant neoplasm of other and unspecified urinary organs, Kidney, except pelvis
146.2
27.7
29
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
4.1
27.6
111
279
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.5
27.2
60
72
Z49.0
ICD-10 Finland
Preparatory care for dialysis
6.5
27.0
71
111
SPAT1153
SPAT
Removal of sutures
1.6
26.7
1013
7319
C03CA01
ATC
furosemide; systemic
1.5
26.5
1084
7971
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
5.9
26.3
74
127
N28.1
ICD-10 Finland
Cyst of kidney
4.8
26.2
89
190
8010/3-C64.9
ICD-O-3
Carcinoma, NOS, of kidney, NOS
+∞
26.1
25
*
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.9
25.6
401
2228
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
25.4
530
3242
D44.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Adrenal gland
6.0
25.2
70
118
L03AA04
ATC
NA
16.2
24.9
40
25
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
4.5
24.9
90
205
WX704
NOMESCO Finland
Intubation
2.3
24.8
245
1121
N18.0
ICD-10 Finland
End-stage renal disease
5.3
24.5
76
147
GDB11
NOMESCO Finland
Thoracoscopic wedge resection of lung
8.8
24.2
52
60
WW500
NOMESCO Finland
Blood transfusion
2.7
24.1
167
630
Z85.5
ICD-10 Finland
Personal history of malignant neoplasm of urinary tract
56.4
24.0
28
5
L01EX03
ATC
pazopanib; oral
+∞
24.0
23
*
L01XE05
ATC
[U] sorafenib; oral
17.8
23.9
37
21
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
4.9
23.8
79
165
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.6
23.6
185
748
ZXA00
NOMESCO Finland
Right side
1.5
23.0
872
6248
Z49.1
ICD-10 Finland
Extracorporeal dialysis
4.8
23.0
78
167
Z90.5
ICD-10 Finland
Acquired absence of kidney
65.4
22.8
26
*
PC5DT
NOMESCO Finland
Embolisation of tumor of kidney
120.9
22.6
24
*
R50.9
ICD-10 Finland
Fever, unspecified
1.8
22.2
430
2560
JN3CG
NOMESCO Finland
Extensive MRI examination of abdomen with high intensity magnet
10.4
22.0
43
42
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
2.5
22.0
173
705
KA3CT
NOMESCO Finland
Biopsy of kidney under CT guidance
+∞
21.9
21
*
KB1CG
NOMESCO Finland
Extensive MRI examination of urinary tract with high intensity magnet
62.9
21.9
25
*
2395A
ICD-9 Finland
Neoplasm of unspecified nature, Other genito-urinary organs
18.5
21.7
33
18
B03XA02
ATC
darbepoetin alfa; parenteral
3.7
21.1
93
255
J01MA02
ATC
ciprofloxacin; systemic
1.5
21.0
1194
9295
L03AB04
ATC
interferon alfa-2a; parenteral
16.7
20.9
33
20
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.5
20.7
913
6737
C79.7
ICD-10 Finland
Secondary malignant neoplasm of adrenal gland
22.5
20.4
29
13
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.6
20.1
537
3507
PHN71
NOMESCO Finland
Excision of tumor mass from inferior vena cava
+∞
19.8
19
*
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
2.4
19.8
177
772
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
11.0
19.6
37
34
L03AB05
ATC
interferon alfa-2b; parenteral
10.1
19.3
38
38
WX110
NOMESCO Finland
Local anesthesy
1.4
19.2
1800
15309
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.8
18.9
354
2080
H02AB02
ATC
dexamethasone; systemic
1.9
18.9
315
1779
L01EK01
ATC
axitinib; oral
+∞
18.8
18
*
C02AC05
ATC
moxonidine; oral
2.3
18.6
182
828
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
6.5
18.5
48
75
M05BX04
ATC
denosumab; parenteral
2.3
17.8
174
790
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
17.7
155
668
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
17.7
195
938
137
Kela drug reimbursment
Uraemia requiring dialysis
5.5
17.3
51
94
KH1AD
NOMESCO Finland
CT of urinary organs
2.7
17.1
119
454
D41.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Urinary organ, unspecified
25.7
16.9
23
9
H05BX01
ATC
cinacalcet; oral
7.6
16.9
39
52
PJD43
NOMESCO Finland
Excision of aortic lymph nodes
22.0
16.8
24
11
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
4.1
16.8
66
165
M907, C6488
ICD-10 Finland
NA
+∞
16.7
16
*
BCA31
NOMESCO Finland
Endoscopic unilateral adrenalectomy
10.4
16.6
32
31
RJ128
NOMESCO Finland
NA
15.1
16.6
27
18
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
3.4
16.5
80
239
A02BC02
ATC
pantoprazole; systemic
1.4
16.4
1855
16079
C08CA02
ATC
felodipine; oral
1.7
16.3
338
2045
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
2.1
16.2
185
905
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
5.3
15.9
48
92
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
2.9
15.8
98
349
U79
ICPC
Neoplasm urinary tract unspecified
60.3
15.8
18
*
ZXC96
NOMESCO Finland
Robot assisted procedure
2.7
15.7
111
427
Z94.0
ICD-10 Finland
Kidney transplant status
4.7
15.6
52
111
320
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
7.8
15.5
35
45
ZX120
NOMESCO Finland
Intravenous
1.8
15.5
292
1717
V03AE02
ATC
sevelamer; oral
8.0
15.3
34
43
KAC20
NOMESCO Finland
Nephroureterectomy
17.8
15.1
23
13
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.2
15.0
150
691
Z31.5
ICD-10 Finland
Genetic counselling
2.7
15.0
101
378
196
Kela drug reimbursment
Paricalcitol and cinacalcet
8.5
14.9
32
38
A10BH05
ATC
linagliptin; oral
2.1
14.9
176
873
J01MA12
ATC
levofloxacin; systemic
1.5
14.8
576
4095
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
14.3
402
2645
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
13.9
485
3362
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.5
13.8
109
449
R4190
NOMESCO Finland
Nutritional therapy
2.7
13.7
94
356
E87.5
ICD-10 Finland
Hyperkalaemia
3.1
13.6
73
237
B05DA
ATC
Isotonic solutions
5.4
13.6
40
75
C08CA13
ATC
lercanidipine; oral
1.6
13.6
415
2787
C78.8
ICD-10 Finland
Secondary malignant neoplasm of other and unspecified digestive organs
8.3
13.5
29
35
7124
FHL
Nephrectomy (simple
140.5
13.5
14
*
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
3.5
13.0
60
174
321
Kela drug reimbursment
Paricalcitol and cinacalcet
6.3
12.7
33
53
WX290
NOMESCO Finland
Other blockade of nerve
1.4
12.7
912
7239
XKD00
NOMESCO Finland
Uroflowmetry
1.4
12.7
599
4413
AA1BD
NOMESCO Finland
Extensive CT of head and brain
2.6
12.5
91
359
PG5DE
NOMESCO Finland
Ultrasound examination of injection gate to artery or vein with Doppler method
10.1
12.5
24
24
C68.9
ICD-10 Finland
Malignant neoplasm: Urinary organ, unspecified
130.5
12.4
13
*
L01EG02
ATC
everolimus; oral (mammalian target of rapamycin kinase inhibitors (mtor))
130.5
12.4
13
*
B01AB04
ATC
dalteparin; parenteral
2.0
12.4
155
789
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.9
12.3
184
999
127
Kela drug reimbursment
Transplant complication
3.5
12.2
55
157
A06AD11
ATC
lactulose; oral
1.5
12.1
463
3265
C07AB02
ATC
metoprolol; systemic
1.4
12.1
674
5120
J01DB01
ATC
cefalexin; oral
1.3
12.1
2262
20649
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.9
12.0
188
1040
L02AB02
ATC
medroxyprogesterone; systemic (progestogens)
6.2
12.0
31
50
Z49.2
ICD-10 Finland
Other dialysis
5.0
11.7
36
72
KA2AE
NOMESCO Finland
Ultrasound examination transplanted kidney
5.5
11.6
33
60
U06
ICPC
Haematuria
2.5
11.6
89
363
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
3.9
11.5
46
119
JN6AD
NOMESCO Finland
CT of torso and neck
3.7
11.5
49
134
C09AA02
ATC
enalapril; systemic
1.4
11.5
647
4919
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
9.6
11.2
22
23
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
9.6
11.2
22
23
G04CA02
ATC
tamsulosin; oral
1.3
11.2
869
6957
N99.0
ICD-10 Finland
Postprocedural renal failure
17.1
11.2
17
10
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
11.1
508
3713
E83.50
ICD-10 Finland
Hypercalcemia
3.5
11.1
51
149
KA2AT
NOMESCO Finland
Biopsy of transplanted kidney with ultrasound guidance
6.4
11.1
28
44
JMA10
NOMESCO Finland
Transabdominal total splenectomy
6.1
11.0
29
48
D41
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour of urinary organs
43.4
10.9
13
*
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.8
10.8
44
116
KAS10
NOMESCO Finland
Allogenic transplantation of kidney from cadaver donor
4.5
10.8
37
83
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.6
10.8
279
1792
WX892
NOMESCO Finland
Monitored bed care
1.7
10.8
228
1389
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
2.5
10.7
82
331
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.3
10.7
804
6396
KKB10
NOMESCO Finland
Excision of retroperitoneal tumour
17.9
10.7
16
9
L04AA06
ATC
mycophenolic acid; systemic
3.1
10.6
57
188
B03XA01
ATC
erythropoietin; parenteral
3.8
10.5
43
114
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
9.2
10.5
21
23
M10.9
ICD-10 Finland
Gout, unspecified
1.7
10.4
221
1347
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
2.6
10.3
74
292
WW200
SPAT
NA
0.5
10.2
74
1481
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.6
10.2
45
128
TJA35
NOMESCO Finland
Removal of peritoneal dialysis catheter
7.5
10.2
23
31
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.6
10.1
283
1857
NK6AN
NOMESCO Finland
Total body bone isotope imaging
2.2
10.1
98
448
JLC10
NOMESCO Finland
Distal pancreatectomy
8.4
10.0
21
25
B05DB
ATC
Hypertonic solutions
5.0
10.0
31
63
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.0
10.0
57
193
E89.6
ICD-10 Finland
Postprocedural adrenocortical(-medullary) hypofunction
40.2
10.0
12
*
JAH00
NOMESCO Finland
Laparotomy
2.4
9.9
84
361
WX306
NOMESCO Finland
Lumbar epidural anesthesy
2.0
9.9
118
589
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
7.6
9.9
22
29
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
20.1
9.8
14
7
A04AA01
ATC
ondansetron; systemic, rectal
1.8
9.7
174
1008
B02AA02
ATC
tranexamic acid; systemic
1.6
9.7
269
1759
C09BA02
ATC
enalapril and diuretics; systemic
1.6
9.6
277
1830
WX882
NOMESCO Finland
High dependency care
2.2
9.5
93
429
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.4
9.5
457
3367
KB1DG
NOMESCO Finland
Very extensive MRI of urinary tract
100.3
9.4
10
*
C68.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of urinary organs
30.1
9.4
12
*
PHN70
NOMESCO Finland
Plastic repair of inferior vena cava
+∞
9.4
9
*
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
9.3
899
7399
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
2.7
9.2
60
224
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
5.0
9.2
28
56
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.9
9.2
140
770
TK820
NOMESCO Finland
Peritoneal dialysis
5.5
9.2
26
48
WF004
NOMESCO Finland
Palliative radiotherapy
2.4
9.2
73
305
N18.5
ICD-10 Finland
Chronic kidney disease, stage 5
5.9
9.0
24
41
N02AA01
ATC
morphine; systemic, rectal
2.9
9.0
52
179
N18
ICD-10 Finland
Chronic kidney disease
3.1
8.9
46
148
N03AX16
ATC
pregabalin; oral
1.3
8.9
598
4658
M84.4
ICD-10 Finland
Pathological fracture, not elsewhere classified
7.4
8.9
20
27
Q60.0
ICD-10 Finland
Renal agenesis, unilateral
24.1
8.9
12
5
105
Kela drug reimbursment
Adrenal cortical hypofunction
10.7
8.8
16
15
N19
ICD-10 Finland
Unspecified kidney failure
2.0
8.8
116
605
JN1AD
NOMESCO Finland
CT examination of upper part of abdomen
5.9
8.7
23
39
H03AA01
ATC
levothyroxine sodium; systemic
1.4
8.6
523
4007
A79
ICPC
Malignancy NOS
3.0
8.6
47
158
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
8.5
1164
9989
Z80.8
ICD-10 Finland
Family history of malignant neoplasm of other organs or systems
10.0
8.5
16
16
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.3
8.5
74
324
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
2.5
8.4
62
249
Z80.5
ICD-10 Finland
Family history of malignant neoplasm of urinary tract
90.3
8.4
9
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
4.7
8.4
27
58
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.8
8.4
140
793
XX9XW
NOMESCO Finland
NA
4.2
8.4
30
72
N04.1
ICD-10 Finland
Nephrotic syndrome, focal and segmental glomerular lesions
12.8
8.4
14
11
Q85.82
ICD-10 Finland
of Hipple-Lindau syndrome
+∞
8.3
8
*
9680/3-C64.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of kidney, NOS
+∞
8.3
8
*
1891X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Renal pelvis[NEOPLASMA MALIGNUM PELVIS RENIS,EI HIST VAHV]
+∞
8.3
8
*
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.5
8.3
267
1811
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.3
8.2
852
7051
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
3.1
8.2
43
141
OAB42
NOMESCO Finland
Guidance related to known health problem
5.4
8.1
23
43
N25.8
ICD-10 Finland
Other disorders resulting from impaired renal tubular function
4.7
8.1
26
56
A10AE04
ATC
insulin glargine; parenteral
1.5
8.1
263
1788
GDA20
NOMESCO Finland
Excision of lesion of lung
10.0
8.0
15
15
N05CF01
ATC
zopiclone; oral
1.3
8.0
887
7405
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.3
8.0
68
295
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
8.0
197
1255
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.2
7.9
18
25
H02AB06
ATC
prednisolone; systemic
1.2
7.9
1253
10913
C07AB07
ATC
bisoprolol; oral
1.2
7.9
1452
12857
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.1
7.9
85
409
R33
ICD-10 Finland
Retention of urine
1.5
7.9
272
1874
PBL09
NOMESCO Finland
Construction of arteriovenous fistula from brachial artery
7.8
7.9
17
22
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.0
7.7
42
142
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
1.8
7.7
118
654
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
3.8
7.6
30
79
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
7.6
76
355
PG5AC
NOMESCO Finland
Contrast examination of injection gate to artery or vein
18.4
7.6
11
6
B03XA03
ATC
methoxy polyethylene glycol-epoetin beta; parenteral
4.9
7.6
23
47
KAB00
NOMESCO Finland
Biopsy of kidney or pelvis of kidney
25.0
7.6
10
*
A04AA02
ATC
granisetron; systemic, transdermal
1.7
7.5
152
918
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.5
7.5
290
2048
J01CA04
ATC
amoxicillin; systemic
1.2
7.4
2086
19288
7121
FHL
Removal of local change or renal resection (eg cyst)
80.2
7.4
8
*
PC5NT
NOMESCO Finland
Endovascular embolisation for kidney bleeding with radiological guidance
80.2
7.4
8
*
UJF32
NOMESCO Finland
Coloscopy
1.3
7.4
707
5777
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.5
7.4
245
1673
NA049
NOMESCO Finland
Radiotherapy of methastasis in spine
13.4
7.4
12
9
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
7.3
94
487
E21.09
ICD-10 Finland
Other primary hyperparathyroidism
2.6
7.3
49
190
A12AA12
ATC
[U] calcium acetate anhydrous; systemic
6.2
7.2
18
29
E03.2
ICD-10 Finland
Hypothyroidism due to medicaments and other exogenous substances
7.3
7.2
16
22
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
3.7
7.1
29
79
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.2
7.1
1175
10242
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.4
7.1
381
2853
J01EA01
ATC
trimethoprim; systemic
1.3
7.1
582
4658
I12.0
ICD-10 Finland
Hypertensive renal disease with renal failure
3.0
7.0
37
123
SPAT1254
SPAT
Administration of medicine
1.4
7.0
389
2931
A06AH03
ATC
naloxegol; oral
3.0
7.0
38
129
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.0
7.0
81
403
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.3
7.0
485
3791
PH1AE
NOMESCO Finland
Ultrasound examination of upper extremity veins
2.8
7.0
41
146
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
5.2
6.9
20
39
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
1.8
6.9
111
626
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.9
906
7695
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
1.8
6.9
105
581
GDA21
NOMESCO Finland
Thoracoscopic excision of lesion of lung
13.8
6.9
11
8
C09CA01
ATC
losartan; oral
1.3
6.9
680
5580
L04AD02
ATC
tacrolimus; systemic (calcineurin inhibitors)
3.8
6.8
27
72
N05BA04
ATC
oxazepam; oral
1.3
6.8
572
4590
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
6.8
174
1118
PC5SC
NOMESCO Finland
Selective angiography of kidney artery with X-ray
6.7
6.8
16
24
N28.9
ICD-10 Finland
Disorder of kidney and ureter, unspecified
6.7
6.8
16
24
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
3.4
6.7
30
89
A41.9
ICD-10 Finland
Sepsis, unspecified
1.8
6.7
107
601
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
2.9
6.6
38
132
212
Kela drug reimbursment
Gout
2.0
6.6
74
366
TJA33
NOMESCO Finland
Percutaneous introduction of peritoneal dialysis catheter
7.8
6.6
14
18
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
4.2
6.6
23
55
JN1BG
NOMESCO Finland
MRI examination of upper part of abodmen with high intensity magnet
3.4
6.6
29
85
AA049
NOMESCO Finland
Radiotherapy of metasthasis in the brain
12.3
6.6
11
9
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.5
6.6
200
1340
JAH01
NOMESCO Finland
Laparoscopy
2.0
6.5
82
425
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.4
6.5
342
2556
E66.8
ICD-10 Finland
Other obesity
1.9
6.5
92
498
GDB10
NOMESCO Finland
Wedge resection of lung
6.2
6.5
16
26
E66.01
ICD-10 Finland
Obesity due to excess calories
1.7
6.4
130
788
2230A
ICD-9 Finland
Benign neoplasm of kidney and other urinary organs, Kidney, except pelvis
70.0
6.4
7
*
1XC17
NOMESCO Finland
NA
70.0
6.4
7
*
D30.1
ICD-10 Finland
Benign neoplasm: Renal pelvis
70.0
6.4
7
*
PBM10
NOMESCO Finland
Closure of arteriovenous fistula of radial artery
8.1
6.3
13
16
C03AA03
ATC
hydrochlorothiazide; oral
1.4
6.3
273
1973
TK810
NOMESCO Finland
Hemofiltration
3.7
6.3
25
68
8316/3-C64.9
ICD-O-3
Cyst-associated renal cell carcinoma of kidney, NOS
+∞
6.2
6
*
8890/3-C64.9
ICD-O-3
Leiomyosarcoma, NOS, of kidney, NOS
+∞
6.2
6
*
1890C
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Kidney, except pelvis[NEOPL MAL RENIS PELVI EXCEPTO,MUU/TARK MÄÄR SYÖPÄ]
+∞
6.2
6
*
8318/3-C64.9
ICD-O-3
Renal cell carcinoma, sarcomatoid of kidney, NOS
+∞
6.2
6
*
1899X
ICD-9 Finland
Malignant neoplasm of kidney and other and unspecified urinary organs, Urinary organ, site unspecified[NEOPLASMA MAL ORG URIN NUD,EI HIST VAHV]
+∞
6.2
6
*
KAC96
NOMESCO Finland
Other nephrectomy
+∞
6.2
6
*
KAD10
NOMESCO Finland
Heminephrectomy
+∞
6.2
6
*
C68
ICD-10 Finland
Malignant neoplasm of other and unspecified urinary organs
+∞
6.2
6
*
H02AB09
ATC
hydrocortisone; systemic
2.2
6.2
60
280
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.3
6.2
690
5736
TKC20
NOMESCO Finland
Catheterisation of bladder
1.5
6.2
216
1494
R04.2
ICD-10 Finland
Haemoptysis
1.8
6.2
99
560
JAK10
NOMESCO Finland
Laparotomy and insertion of peritoneal dialysis catheter
4.0
6.1
22
55
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
802
2986
3.20
162.72
9.4
6.9
11.6
10.8
mmol/l
2.28
761
2821
2089
13026
2.56
149.95
5.1
4.2
—
—
—
0
0
548
1772
3.49
138.23
7.7
9.9
—
—
—
0
0
2030
12873
2.42
134.50
8.1
4.9
34.2
34.8
g/l
3.81
1917
11917
770
3115
2.90
132.21
7.4
8.0
120.0
120.9
g/l
0.70
753
2988
818
3429
2.82
131.28
7.0
7.5
96.6
95.4
%
8.22
790
3292
919
4118
2.69
129.26
9.2
5.8
1.1
1.0
mmol/l
5.77
865
3814
2069
13538
2.34
123.02
10.4
6.2
1.2
1.2
mmol/l
0.11
1955
12209
854
3795
2.67
121.19
7.0
7.2
-0.2
1.1
mmol/l
17.71
685
2937
852
3802
2.65
119.72
7.0
7.2
5.3
5.1
kpa
7.51
823
3610
851
3802
2.65
119.23
7.0
7.2
13.6
12.0
kpa
13.80
821
3610
1542
9207
2.23
110.47
4.8
3.5
83.7
84.1
e6/l
0.01
1328
7205
872
4085
2.52
109.59
8.4
6.8
104.8
104.4
mmol/l
2.23
860
3971
2519
18399
2.41
109.29
6.1
4.8
621.8
1556.6
e6/l
0.86
35
318
821
3747
2.57
108.95
4.4
4.2
236.3
245.1
u/l
0.87
800
3522
1431
8394
2.21
105.97
4.6
3.3
0.3
0.5
e6/l
1.22
1220
6426
1187
6485
2.27
104.35
3.5
2.7
3.5
4.7
e6/l
4.55
1077
5693
2131
14895
2.15
97.23
12.2
7.0
1.2
1.2
mmol/l
0.53
1800
12544
1626
10378
2.08
93.20
5.5
3.9
68.7
117.1
e6/l
2.02
1369
7645
2119
15025
2.08
89.78
11.8
6.3
10.8
12.4
umol/l
5.51
2042
14259
465
1751
2.92
88.57
8.1
9.2
23.4
24.3
mmol/l
10.79
449
1624
2728
21592
2.31
83.15
14.6
7.7
82.4
80.8
u/l
1.11
2651
20268
1188
6985
2.07
82.55
2.9
2.5
—
—
—
0
0
1868
12961
1.97
80.34
11.2
10.7
1.2
1.3
inr
6.95
521
3537
617
2850
2.42
77.16
7.5
6.8
1.2
1.4
mmol/l
11.35
600
2739
2293
17220
2.01
76.71
7.0
5.0
6.9
6.9
mmol/l
0.11
2220
16246
523
2287
2.52
73.42
6.1
3.9
134.8
97.6
ng/l
8.20
465
1948
897
4952
2.10
72.14
4.6
3.2
0.8
0.8
mmol/l
0.30
855
4611
2114
15831
1.88
66.49
14.2
8.8
4.3
4.3
e9/l
0.46
1878
13725
867
4876
2.04
65.38
4.2
3.1
1.8
1.7
e6/l
0.13
549
2745
903
5180
2.01
64.27
3.9
2.9
0.8
1.2
e6/l
3.29
583
3026
1361
8973
1.86
63.49
4.2
2.6
66.0
59.3
u/l
1.44
1281
8248
1446
9771
1.83
61.85
6.7
3.4
2.4
2.3
mmol/l
2.90
1306
8386
494
2356
2.28
56.11
5.2
2.2
393.5
372.0
nmol/l
1.59
474
2142
739
4252
1.94
50.50
4.1
2.6
20.3
22.5
%
4.33
629
3617
1111
7265
1.78
50.45
5.4
4.1
91.2
84.6
%
13.71
1093
7100
769
4508
1.91
49.57
4.0
2.5
2.1
2.3
g/l
13.48
723
4176
809
4829
1.88
49.29
3.9
2.5
10.8
12.6
umol/l
10.89
758
4476
817
4935
1.86
47.74
2.2
2.0
30.0
30.1
s
0.38
810
4780
160
469
3.53
45.73
1.5
1.4
16.2
8.7
u/l
4.59
123
377
887
5584
1.79
44.87
6.1
3.1
2.5
2.5
mmol/l
5.93
807
4871
213
766
2.90
43.27
4.9
3.3
1.8
1.7
mg/l
2.34
194
689
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
286
1196
2.52
43.19
2.8
2.7
0.4
0.3
u/ml
0.71
135
686
324
1542
2.22
36.27
7.2
3.9
23.6
24.1
mmol/l
2.31
300
1378
1763
13850
1.56
35.09
7.0
5.8
1.9
1.9
e9/l
0.14
1546
12021
533
3077
1.87
34.80
6.5
3.7
1.2
2.0
mmol/l
4.53
436
2459
1782
14059
1.56
34.61
7.1
5.9
0.2
0.2
e9/l
0.80
1561
12172
399
2099
2.02
34.29
7.2
6.9
24.2
24.5
mmol/l
0.60
378
1950
1671
13062
1.55
33.34
7.2
6.2
25.0
26.3
%
4.69
1570
12056
529
3086
1.84
33.30
6.3
3.7
5.9
5.8
kpa
0.40
516
2985
1637
12773
1.54
32.70
7.1
6.0
2.9
2.9
%
0.28
1550
11823
1097
7832
1.59
32.47
3.7
2.9
2785.6
5925.6
umol/l
1.91
952
6672
1687
13289
1.53
31.99
5.1
3.8
0.0
0.0
estimate
0.50
400
2451
1173
8551
1.57
31.51
4.7
3.2
31.8
39.1
u/l
2.25
1121
8091
1639
12861
1.53
31.44
7.0
6.0
59.7
58.3
%
4.97
1550
11935
185
735
2.60
30.95
6.4
7.3
105.8
105.4
mmol/l
0.94
169
651
1695
13454
1.52
30.42
5.2
3.9
0.0
0.0
estimate
0.20
400
2380
102
301
3.46
28.88
1.5
1.3
—
—
nmol/l
—
0
0
1667
13285
1.50
28.69
6.8
5.1
0.0
0.0
estimate
0.00
408
2480
108
343
3.22
27.21
1.6
1.3
0.7
0.7
nmol/l
0.07
103
325
112
374
3.06
25.95
1.7
1.4
34.4
30.5
iu/l
0.44
78
309
764
5242
1.59
25.75
1.9
1.9
—
—
—
0
0
106
346
3.13
25.53
1.6
1.3
0.2
0.3
nmol/l
0.57
11
25
462
2796
1.75
25.25
3.0
2.6
65.6
66.1
g/l
0.64
429
2538
385
2235
1.81
24.19
1.8
1.6
—
—
—
0
0
1236
9527
1.47
23.71
3.7
3.2
7.1
7.5
mmol/l
2.99
1018
7914
2309
20045
1.47
23.25
5.0
4.1
18.6
13.6
mm/h
22.24
2131
18389
503
3196
1.67
22.87
4.1
3.7
—
—
—
0
0
1202
9312
1.45
22.03
3.8
3.3
609.8
285.7
mg/l
1.48
818
6052
59
145
4.12
21.76
1.3
1.3
37.1
28.5
u/l
0.86
54
114
495
3192
1.64
21.13
3.1
2.8
8.0
9.6
umol/l
1.01
439
2811
1287
10169
1.43
20.89
5.6
4.1
—
—
—
0
0
1248
9830
1.42
20.51
4.6
4.0
24.6
8.8
mg/mmol
10.33
835
6349
505
3318
1.61
19.91
3.0
4.1
8.1
22.6
ug/l
2.19
405
2753
159
723
2.26
19.78
5.2
5.0
2.4
2.6
mmol/l
0.29
107
493
33
53
6.28
19.72
10.9
2.3
56.2
46.8
u/l
0.42
19
14
340
2021
1.76
19.58
5.0
3.7
1.0
1.9
mmol/l
3.56
243
1469
238
1298
1.90
18.13
4.5
3.1
4.2
4.4
pmol/l
1.00
213
1124
1324
10712
1.39
17.93
3.7
2.8
219.3
164.3
ug/l
5.95
1199
9725
347
2125
1.70
17.91
5.1
3.8
5.1
5.1
kpa
0.06
326
1960
250
1392
1.86
17.85
5.7
5.3
1.7
1.6
%
1.17
232
1302
392
2484
1.65
17.77
7.4
3.9
1.2
1.2
mmol/l
0.40
365
2169
534
3651
1.55
17.59
1.8
1.8
—
—
—
0
0
436
2848
1.61
17.48
2.1
2.2
0.2
0.2
g/l
2.70
409
2646
246
1372
1.85
17.47
5.8
5.3
1.0
0.9
%
3.43
229
1283
562
3891
1.53
17.47
2.7
2.5
1.8
1.8
%
0.24
511
3416
126
551
2.34
17.20
4.0
5.5
834.9
3289.7
iu/ml
0.44
14
83
952
7326
1.42
17.14
5.7
4.2
0.0
0.0
estimate
0.52
371
2324
396
2542
1.63
17.03
4.7
3.0
4.8
4.5
kpa
1.63
383
2452
216
1169
1.90
16.84
2.8
3.3
12820.9
2289.2
u/ml
0.43
188
1010
529
3649
1.53
16.67
1.8
1.8
—
—
—
0
0
399
2617
1.59
15.65
3.1
2.4
68.8
38.3
u/l
0.47
360
2228
140
667
2.15
15.57
1.3
1.3
—
—
—
0
0
270
1607
1.74
15.41
1.6
1.7
1.8
1.5
g/l
3.80
225
1372
113
505
2.28
14.71
1.5
1.8
2.4
4.5
iu/l
3.42
29
158
105
455
2.35
14.68
1.4
1.5
1572.8
1869.9
e6/l
0.34
71
328
973
7691
1.37
14.46
2.3
2.3
3.3
3.0
mg/l
2.87
833
6504
113
516
2.23
13.99
1.4
1.5
32.9
31.6
g/l
0.48
101
463
430
2945
1.53
13.86
3.0
2.5
66.3
68.6
e9/l
0.72
326
2256
238
1442
1.70
12.73
2.0
2.0
1.5
2.4
ug/l
0.86
215
1262
138
711
1.98
12.49
3.2
2.5
16.7
16.0
%
0.93
80
370
350
2349
1.55
12.33
4.2
2.8
48.3
61.8
ml/min/173m2
17.11
224
986
1404
11921
1.30
12.23
16.0
10.3
0.0
0.0
e9/l
0.91
1151
9717
93
415
2.28
12.21
1.3
1.4
82051.7
81312.6
e6/l
0.01
50
258
185
1080
1.75
11.33
2.4
3.4
1.5
2.4
ratio
0.64
12
76
150
824
1.86
11.23
3.4
3.3
8.3
8.0
kpa
0.94
143
764
742
5815
1.35
11.20
1.7
1.7
1.6
1.5
mg/l
0.51
601
4533
1371
11709
1.29
11.07
4.7
4.0
46.3
58.6
ng/l
0.80
1115
8944
39
117
3.36
10.94
26.0
28.9
83.6
119.4
ug/l
5.02
33
102
2830
26586
1.38
10.86
26.9
16.7
35.0
26.7
mg/l
24.73
2624
21632
187
1110
1.72
10.80
2.4
3.4
60.8
108.7
mg/l
0.45
153
896
74
316
2.37
10.79
1.3
1.4
226.3
273.2
pmol/l
0.92
62
238
186
1109
1.72
10.58
2.4
3.4
82.9
66.3
mg/l
0.23
151
900
145
805
1.84
10.52
2.2
2.4
4.0
3.6
g/l
1.45
140
762
18
30
6.03
10.38
4.6
5.7
59.7
52.5
ug/min
0.17
18
24
198
1211
1.67
10.25
1.3
1.2
159.9
136.2
iu/ml
0.29
59
416
1271
10831
1.28
10.21
2.7
2.2
79.9
78.4
nmol/l
0.91
1147
9489
165
972
1.73
9.82
1.3
1.3
—
—
—
0
0
168
997
1.72
9.74
4.9
4.0
4.0
3.9
mmol/l
1.78
159
921
19
36
5.30
9.63
4.3
5.7
—
—
—
0
0
30
83
3.64
9.53
1.9
2.0
—
—
—
0
0
155
905
1.75
9.53
2.0
1.8
—
—
—
0
0
204
1282
1.63
9.52
5.8
4.1
24.1
24.8
mmol/l
2.45
192
1179
152
893
1.73
9.15
3.8
3.3
23.6
25.0
mmol/l
3.91
140
771
105
550
1.94
9.15
1.2
1.6
—
—
—
0
0
128
718
1.81
9.03
1.3
1.6
—
—
—
0
0
130
734
1.80
8.97
1.3
1.5
—
—
—
0
0
131
746
1.79
8.80
1.3
1.6
—
—
—
0
0
46
173
2.68
8.79
1.8
2.1
—
—
—
0
0
68
309
2.22
8.66
3.8
2.7
—
—
—
0
0
287
1999
1.48
8.45
1.9
1.7
—
—
—
0
0
181
1140
1.62
8.40
2.4
2.6
—
—
—
0
0
139
821
1.72
8.24
2.6
2.3
201.0
86.2
ug/min
1.78
86
494
61
271
2.27
8.21
1.2
1.3
17.0
13.9
u/l
0.29
54
252
275
1912
1.48
8.18
1.6
1.5
—
—
—
0
0
46
180
2.58
8.16
1.8
2.1
18.4
15.2
%
0.32
14
76
98
525
1.89
8.03
3.7
3.4
59.9
58.6
%
0.46
98
525
2102
19277
1.24
7.97
6.6
3.7
15.2
15.0
pmol/l
2.85
1920
17188
124
719
1.75
7.86
2.2
2.4
220.9
201.5
%
1.41
119
689
1145
9869
1.24
7.78
3.2
3.1
2365.7
1707.2
ng/l
2.94
1025
8576
125
729
1.74
7.77
3.1
2.1
129.7
127.9
g/l
0.29
102
535
226
1542
1.50
7.39
4.0
2.5
1.2
1.2
%
0.03
226
1532
1066
9165
1.24
7.31
2.2
2.2
202.4
229.8
u/l
0.44
1002
8541
131
790
1.68
7.24
2.1
2.2
90.4
88.4
%
0.48
125
758
83
442
1.90
6.97
1.2
1.5
—
—
—
0
0
93
518
1.82
6.80
1.3
1.5
—
—
—
0
0
739
6150
1.26
6.71
4.7
4.0
1447.6
428.0
ng/l
0.42
640
5236
57
269
2.14
6.69
1.9
2.2
694.5
629.6
ml
0.60
42
164
23
69
3.35
6.54
1.2
1.0
393.6
260.0
pmol/l
0.45
15
48
232
1632
1.45
6.53
5.4
3.3
24.2
25.1
mmol/l
3.80
227
1584
172
1139
1.54
6.50
2.3
2.2
491.4
684.3
ug/l
0.40
166
1076
714
5943
1.25
6.44
5.9
4.3
1.0
1.0
kg/l
0.03
121
914
133
833
1.62
6.39
1.4
1.5
249.4
268.8
ug/g
0.54
82
508
193
1316
1.49
6.37
1.8
2.4
4.0
3.8
g/l
0.50
134
949
193
1317
1.49
6.34
1.8
2.4
—
—
—
0
0
193
1318
1.49
6.32
1.8
2.4
7.8
7.4
g/l
1.53
138
984
68
351
1.96
6.30
1.3
1.6
—
—
—
0
0
130
813
1.62
6.29
1.4
1.5
—
—
—
0
0
77
415
1.87
6.28
1.3
1.4
—
—
—
0
0
181
1223
1.51
6.24
1.8
2.5
3.4
3.1
g/l
2.27
137
967
83
463
1.81
6.08
1.3
1.4
—
—
—
0
0
42
182
2.32
6.08
6.9
5.0
30.1
41.0
u/ml
0.20
12
47
1793
16416
1.19
6.06
3.5
3.2
62.0
56.9
u/l
1.26
1642
15002
79
435
1.84
6.04
2.0
1.4
113.2
119.8
u/ml
0.23
25
82
19
54
3.53
5.87
1.0
1.1
0.7
0.7
umol/24h
—
10
30
38
160
2.39
5.87
2.2
1.8
—
—
—
0
0
17
45
3.79
5.81
1.8
1.8
1.4
3.2
ug/l
1.12
12
27
53
258
2.07
5.80
1.2
1.6
—
—
—
0
0
109
667
1.65
5.77
1.7
2.8
28.2
36.0
umol/l
2.94
77
555
180
1238
1.48
5.72
1.8
2.4
10.9
10.3
g/l
0.73
146
1048
78
437
1.80
5.66
1.2
1.3
—
—
—
0
0
74
416
1.80
5.33
1.2
1.5
—
—
—
0
0
18
53
3.41
5.30
2.0
1.7
185.2
163.9
ng/l
0.19
18
53
54
275
1.98
5.26
1.2
1.3
—
—
—
0
0
76
433
1.77
5.24
1.1
1.1
—
—
—
0
0
53
270
1.98
5.16
1.2
1.2
71.8
60.1
u/l
0.27
37
191
29
115
2.53
5.12
1.3
4.3
65.0
61.2
mg/l
0.12
21
81
175
1227
1.45
5.07
2.1
1.8
—
—
—
0
0
162
1123
1.46
4.99
2.0
2.5
1.4
1.1
g/l
0.34
143
965
59
320
1.86
4.80
1.4
1.7
—
—
—
0
0
844
7353
1.20
4.71
1.7
1.6
18.8
20.1
nmol/l
1.56
747
6213
184
1329
1.41
4.56
2.1
2.0
—
—
—
0
0
23
88
2.62
4.39
1.5
1.3
27.7
25.0
%
0.15
23
68
35
163
2.16
4.36
1.6
1.7
4.0
6.8
u/l
0.65
22
82
135
931
1.47
4.31
3.7
3.8
45.9
76.8
u/ml
1.48
127
895
73
437
1.68
4.30
6.5
6.6
11.9
12.3
mg/l
0.27
67
408
24
95
2.54
4.29
2.8
2.7
16.4
19.5
mu/l
0.43
24
89
44
226
1.96
4.25
1.3
1.2
—
—
—
0
0
93
595
1.58
4.21
1.6
1.3
—
—
—
0
0
34
159
2.15
4.21
2.0
1.5
2.0
3.8
u/field
0.61
23
115
141
987
1.45
4.18
1.7
2.4
0.0
0.0
g/l
0.44
132
901
106
703
1.52
4.11
2.9
3.4
32.0
923.7
u/ml
1.56
95
650
94
609
1.56
4.05
1.4
1.4
—
—
—
0
0
2251
21347
1.16
4.02
35.4
20.4
14.2
13.8
%
24.86
2218
20836
84
533
1.59
3.96
3.8
3.7
1.1
1.7
%
1.42
72
399
133
931
1.45
3.96
1.7
2.4
0.0
0.0
g/l
0.00
125
848
131
916
1.45
3.93
1.6
2.4
0.0
0.0
g/l
0.00
125
847
145
1036
1.42
3.87
1.8
2.3
36.1
37.4
g/l
1.67
128
888
137
971
1.43
3.83
1.5
1.5
117.8
231.2
titre
—
9
48
53
301
1.77
3.79
1.4
1.7
—
—
—
0
0
35
174
2.02
3.73
1.6
1.8
—
—
—
0
0
30
142
2.12
3.64
1.1
1.1
—
—
—
0
0
88
578
1.54
3.61
1.6
1.2
65.4
47.6
u/l
0.28
76
501
34
174
1.96
3.38
1.3
1.6
—
—
—
0
0
34
174
1.96
3.38
1.3
1.6
—
—
—
0
0
24
107
2.25
3.38
1.2
1.2
238.5
484.8
ug/l
—
8
50
101
696
1.46
3.32
1.3
1.3
—
—
—
0
0
101
696
1.46
3.32
1.3
1.3
—
—
—
0
0
2572
26609
0.86
3.29
5.3
5.3
2.5
2.6
mmol/l
4.51
2303
24111
15
55
2.73
3.15
1.1
1.3
—
—
—
0
0
2882
28029
1.18
3.09
34.7
19.8
139.0
139.6
mmol/l
28.60
2838
27291
47
276
1.71
3.06
1.2
1.6
—
—
—
0
0
47
276
1.71
3.06
1.2
1.6
—
—
—
0
0
47
276
1.71
3.06
1.2
1.6
—
—
—
0
0
42
243
1.74
2.90
1.5
1.6
—
—
—
0
0
110
1505
0.72
2.88
2.1
1.8
—
—
—
0
0
15
58
2.59
2.87
1.2
1.2
0.8
2.4
mmol/l
—
10
42
89
620
1.45
2.82
1.4
1.6
—
—
—
0
0
70
465
1.52
2.80
1.3
1.2
—
—
—
0
0
1436
13411
1.12
2.78
2.6
2.4
—
—
—
0
0
2883
28090
1.17
2.78
35.1
20.0
4.1
4.0
mmol/l
55.89
2836
27311
10
31
3.23
2.77
1.1
1.1
2.0
1.8
umol/24h
—
10
31
103
741
1.40
2.74
1.2
1.2
—
—
—
0
0
2470
23820
1.13
2.72
7.3
4.5
2.2
2.1
mu/l
0.82
2272
21346
42
248
1.70
2.72
1.1
1.1
—
—
—
0
0
27
139
1.95
2.69
1.4
1.5
0.2
0.2
nmol/l
0.09
21
108
18
79
2.29
2.67
1.2
1.2
—
—
—
0
0
2512
25925
0.88
2.64
4.9
4.7
4.4
4.5
mmol/l
4.01
2272
23634
1337
12462
1.12
2.64
2.1
2.1
93.9
92.8
pmol/l
0.34
740
6574
65
432
1.51
2.62
1.4
1.2
257.4
295.0
u/ml
0.52
43
252
36
206
1.76
2.61
1.3
1.5
—
—
—
0
0
7
15
4.67
2.59
5.3
3.7
—
—
—
0
0
103
750
1.38
2.58
1.2
1.2
—
—
—
0
0
27
143
1.90
2.50
1.0
1.0
—
—
—
0
0
28
151
1.86
2.46
1.3
1.4
—
—
—
0
0
28
151
1.86
2.46
1.3
1.4
—
—
—
0
0
2492
25698
0.89
2.46
4.8
4.7
1.3
1.4
mmol/l
24.45
2239
23232
29
159
1.83
2.43
1.2
1.3
36.3
18.0
u/l
1.15
24
135
59
392
1.51
2.40
2.4
2.2
15.2
24.2
mg/l
1.51
16
87
6
12
5.01
2.40
9.3
5.0
469.7
366.8
umol/l
—
6
12
36
212
1.71
2.39
1.3
1.4
—
—
—
0
0
244
2019
1.22
2.36
2.6
2.7
10.7
10.6
g/l
0.07
219
1837
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
27
147
1.84
2.32
1.2
1.1
—
—
—
0
0
41
254
1.62
2.27
1.3
1.4
—
—
—
0
0
26
142
1.84
2.23
1.6
1.2
—
—
—
0
0
28
157
1.79
2.21
1.4
1.2
—
—
—
0
0
28
157
1.79
2.21
1.2
1.3
1.4
1.0
nmol/l
0.44
19
116
2534
26058
0.89
2.21
5.7
5.0
6.2
6.1
mmol/l
2.23
2273
23315
54
360
1.51
2.19
1.5
1.5
—
—
—
0
0
26
143
1.82
2.18
1.6
1.2
—
—
—
0
0
53
354
1.50
2.14
1.5
1.4
—
—
—
0
0
57
387
1.48
2.13
2.9
2.4
24.8
819.5
u/ml
0.62
57
378
27
153
1.77
2.07
1.4
1.5
61.4
66.6
%
0.32
22
121
7
20
3.50
2.05
2.0
4.3
—
—
—
0
0
53
358
1.49
2.04
1.5
1.5
—
—
—
0
0
34
209
1.63
1.97
1.3
1.4
—
—
—
0
0
31
186
1.67
1.97
1.7
2.2
838.9
645.0
e6/l
—
9
80
108
832
1.31
1.95
1.4
1.4
—
—
—
0
0
27
157
1.73
1.92
1.2
1.8
—
—
—
0
0
27
157
1.73
1.92
1.2
1.8
—
—
—
0
0
27
157
1.73
1.92
1.2
1.8
—
—
—
0
0
27
157
1.73
1.92
1.2
1.8
—
—
—
0
0
41
266
1.55
1.92
2.6
1.9
3.8
2.1
u/field
0.68
19
96
14
65
2.16
1.88
1.1
1.0
—
—
—
0
0
55
382
1.45
1.87
3.5
7.1
7.0
7.6
mmol/l
0.64
43
318
347
3031
1.16
1.87
2.7
2.4
5.3
7.4
ug/l
1.69
305
2644
2421
24884
0.91
1.85
4.3
4.2
1.5
1.3
mmol/l
24.13
2151
22307
51
351
1.46
1.83
1.5
1.5
—
—
—
0
0
51
351
1.46
1.83
1.5
1.5
—
—
—
0
0
16
80
2.00
1.79
1.1
1.1
—
—
—
0
0
51
353
1.45
1.78
1.5
1.5
—
—
—
0
0
49
700
0.70
1.77
1.4
1.7
6.0
3.8
mg/l
0.59
40
508
28
171
1.64
1.70
2.7
1.8
132.0
2549.6
u/l
—
6
56
15
75
2.00
1.69
1.1
1.1
—
—
—
0
0
678
6226
1.11
1.68
1.8
1.8
1249.1
1169.7
nmol/l
0.98
526
4626
88
678
1.31
1.63
1.5
1.9
11.7
13.0
mg/l
0.54
80
621
508
4602
1.12
1.61
28.4
28.7
1.5
1.4
inr
0.39
68
621
20
113
1.77
1.60
1.5
1.4
23.9
23.6
%
0.01
15
104
8
32
2.50
1.59
2.5
2.3
0.3
0.6
u/field
—
8
32
15
77
1.95
1.59
1.1
1.1
—
—
—
0
0
21
121
1.74
1.58
1.1
1.9
—
—
—
0
0
21
121
1.74
1.58
1.1
1.9
—
—
—
0
0
5
15
3.34
1.52
6.2
6.2
—
—
—
0
0
21
123
1.71
1.50
1.1
1.9
—
—
—
0
0
341
3030
1.14
1.49
2.9
2.9
319.5
230.6
ng/l
1.37
321
2770
298
2627
1.15
1.46
2.5
2.2
265.4
159.1
ug/g
0.74
235
2063
27
172
1.57
1.42
1.4
2.3
467.0
547.6
e6/l
0.41
19
150
87
684
1.28
1.42
2.0
1.7
—
—
—
0
0
7
29
2.42
1.39
1.0
1.0
—
—
—
0
0
2561
25062
1.09
1.34
29.8
15.9
61.7
75.2
ml/min/173m2
152.89
2345
20791
0
40
0.00
1.32
0.0
1.5
—
—
—
0
0
46
334
1.38
1.31
3.6
3.8
57.6
58.0
%
0.04
35
204
26
169
1.54
1.28
2.6
3.4
—
—
—
0
0
25
163
1.54
1.22
1.5
2.3
0.3
0.2
e9/l
0.17
19
148
2373
23188
1.08
1.21
30.3
18.1
37.9
39.2
%
6.50
1499
14985
110
909
1.22
1.20
1.4
1.6
—
—
—
0
0
8
39
2.05
1.15
1.8
1.1
—
—
—
0
0
10
183
0.55
1.11
1.3
1.1
—
—
—
0
0
20
127
1.58
1.11
1.5
1.5
1.1
2.4
%
1.11
15
107
20
127
1.58
1.11
1.1
1.2
—
—
—
0
0
21
136
1.55
1.08
1.3
1.4
—
—
—
0
0
14
82
1.71
1.05
1.4
1.1
—
—
—
0
0
9
46
1.96
1.03
1.1
2.3
—
—
—
0
0
59
464
1.28
1.03
1.3
1.2
—
—
—
0
0
119
1009
1.19
1.03
1.2
1.3
—
—
—
0
0
7
34
2.06
1.02
1.1
1.0
—
—
—
0
0
25
358
0.70
1.02
1.1
1.1
—
—
—
0
0
12
68
1.77
1.00
1.9
1.3
12.5
9.2
ug/l
1.01
12
68
130
1117
1.17
0.97
1.6
1.8
37.3
38.7
u/l
0.30
112
946
31
421
0.73
0.94
1.4
1.3
—
—
—
0
0
7
37
1.89
0.94
1.3
1.2
—
—
—
0
0
266
2410
1.11
0.92
2.2
2.2
11.7
12.6
nmol/l
0.93
227
2081
56
447
1.26
0.90
3.5
2.4
4.3
4.1
mmol/l
2.70
56
440
56
447
1.26
0.90
3.5
2.4
104.6
105.4
mmol/l
0.49
56
440
2472
25134
0.94
0.89
7.2
6.4
41.5
40.9
mmol/mol
2.50
2273
22941
2859
28231
1.08
0.89
37.0
19.8
113.3
83.6
umol/l
77.69
2859
28222
5
103
0.48
0.89
1.2
2.1
7066.0
20166.6
e6/l
—
5
64
13
79
1.65
0.88
1.5
1.5
2.3
1.9
umol/l
0.81
13
72
683
6465
1.07
0.87
1.7
1.7
22678990.7
27157396.3
pmol/l
0.07
560
5262
20
138
1.45
0.81
1.1
1.1
—
—
—
0
0
0
24
0.00
0.79
0.0
1.4
—
—
—
0
0
6
33
1.82
0.79
1.2
1.1
—
—
—
0
0
22
156
1.41
0.78
2.4
2.4
—
—
—
0
0
11
66
1.67
0.78
1.5
1.1
—
—
—
0
0
76
642
1.19
0.74
1.8
1.7
—
—
—
0
0
16
108
1.48
0.73
1.2
1.0
—
—
—
0
0
5
25
2.00
0.72
1.0
1.0
—
—
—
0
0
13
84
1.55
0.71
1.1
1.1
—
—
—
0
0
12
76
1.58
0.71
1.1
1.1
775.1
1644.3
miu/ml
3.62
12
76
13
194
0.67
0.71
1.5
1.4
98.1
201.2
pmol/l
—
7
65
5
26
1.92
0.70
1.2
1.1
—
—
—
0
0
149
1332
1.12
0.70
1.3
1.3
256.9
238.9
u/ml
0.08
131
1211
13
85
1.53
0.68
1.1
1.1
—
—
—
0
0
114
1003
1.14
0.68
1.5
1.6
—
—
—
0
0
41
329
1.25
0.67
1.9
1.4
—
—
—
0
0
23
170
1.36
0.67
1.3
1.6
—
—
—
0
0
23
170
1.36
0.67
1.3
1.6
—
—
—
0
0
7
44
1.59
0.65
1.1
1.2
—
—
—
0
0
15
103
1.46
0.65
2.1
2.3
—
—
—
0
0
15
103
1.46
0.65
2.1
2.3
—
—
—
0
0
12
79
1.52
0.62
1.1
1.1
—
—
—
0
0
15
105
1.43
0.60
1.0
1.4
—
—
—
0
0
29
227
1.28
0.59
1.1
1.0
—
—
—
0
0
306
2868
1.07
0.56
1.4
1.4
—
—
—
0
0
42
347
1.21
0.56
2.5
3.9
36.3
39.1
u/ml
0.06
42
338
6
37
1.62
0.55
1.0
1.6
—
—
—
0
0
19
142
1.34
0.54
1.1
1.2
377.9
398.6
u/l
0.03
19
133
13
182
0.71
0.54
1.2
1.2
17.1
12.2
mmol/l
—
5
61
84
742
1.14
0.52
1.8
1.6
0.5
13.1
iu/ml
0.88
14
163
9
135
0.67
0.51
1.3
1.2
—
—
—
0
0
243
2600
0.93
0.51
1.6
1.8
1.6
1.6
%
0.03
206
2211
16
118
1.36
0.50
1.1
1.1
—
—
—
0
0
10
67
1.49
0.49
1.1
1.3
—
—
—
0
0
92
1027
0.89
0.48
1.1
1.0
—
—
—
0
0
7
46
1.52
0.48
1.1
1.8
—
—
—
0
0
7
111
0.63
0.48
1.1
1.1
286.9
225.3
iu/ml
—
7
111
2839
28157
1.05
0.48
17.6
11.1
27.9
26.4
u/l
0.42
2750
26979
43
364
1.18
0.47
1.0
1.2
86.9
202.1
miu/ml
—
10
122
7
48
1.46
0.46
1.0
1.1
—
—
—
0
0
25
201
1.25
0.44
1.1
1.2
—
—
—
0
0
7
51
1.37
0.44
1.0
1.3
—
—
—
0
0
32
383
0.83
0.43
3.3
4.5
285.4
343.3
umol/l
2.04
26
338
9
130
0.69
0.43
1.4
1.6
—
—
—
0
0
13
173
0.75
0.42
1.1
1.1
—
—
—
0
0
13
173
0.75
0.42
1.1
1.1
—
—
—
0
0
13
173
0.75
0.42
1.1
1.1
—
—
—
0
0
6
95
0.63
0.42
1.3
1.4
—
—
—
0
0
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
5
34
1.47
0.40
3.0
4.3
—
—
—
0
0
8
61
1.31
0.39
1.0
1.1
—
—
—
0
0
5
35
1.43
0.39
1.4
1.8
—
—
—
0
0
59
665
0.89
0.39
4.1
3.6
31.3
29.5
mg/l
0.12
37
427
24
291
0.82
0.38
1.5
1.3
41513.1
114862.1
e6/l
0.74
14
206
760
7814
0.96
0.38
3.1
3.2
0.9
0.8
ug/l
0.95
581
5469
23
280
0.82
0.38
1.3
1.5
17.4
26.5
%
0.93
14
170
5
36
1.39
0.38
1.0
1.9
—
—
—
0
0
13
170
0.76
0.38
1.1
1.1
—
—
—
0
0
13
170
0.76
0.38
1.1
1.1
—
—
—
0
0
42
364
1.16
0.37
3.1
3.6
—
—
—
0
0
1070
10932
0.97
0.37
4.4
4.5
23.3
22.0
%
2.07
584
5625
5
37
1.35
0.37
1.0
1.1
—
—
—
0
0
13
169
0.77
0.37
1.9
1.9
19.1
17.0
nmol/l
0.38
13
155
8
116
0.69
0.36
2.1
2.4
1353.3
6630.3
e6/l
—
8
91
10
135
0.74
0.36
1.1
1.1
—
—
—
0
0
27
321
0.84
0.36
1.6
1.8
—
—
—
0
0
12
90
1.33
0.35
1.7
1.6
—
—
—
0
0
6
42
1.43
0.35
1.2
1.2
—
—
—
0
0
41
358
1.15
0.34
1.5
1.4
—
—
—
0
0
65
588
1.11
0.32
1.2
1.3
4.0
3.9
mmol/l
0.31
60
549
12
92
1.31
0.31
1.1
1.2
—
—
—
0
0
13
101
1.29
0.31
19.3
14.8
1589.8
1396.8
nmol/l
0.41
13
101
361
3746
0.96
0.31
1.2
1.2
16.6
14.6
u/ml
0.14
117
1341
1382
13611
1.03
0.30
5.1
5.2
3.4
3.9
ug/l
0.31
1239
12127
2891
29059
0.97
0.30
42.6
24.4
7.2
6.9
e9/l
12.04
2833
28073
66
601
1.10
0.29
1.7
1.5
1.0
0.8
nmol/l
1.33
58
489
2891
29056
0.97
0.29
42.8
24.6
129.7
134.8
g/l
50.22
2862
28529
2891
29051
0.97
0.28
42.6
24.4
4.4
4.5
e12/l
17.05
2834
28067
19
158
1.20
0.28
1.8
1.4
0.5
1.3
u/ml
0.62
13
82
8
63
1.27
0.27
1.0
1.1
—
—
—
0
0
2891
29046
0.97
0.27
42.6
24.4
244.5
239.9
e9/l
2.90
2842
28173
90
839
1.07
0.25
1.2
1.2
0.5
0.9
u/ml
—
7
70
6
84
0.71
0.24
2.5
3.1
—
—
—
0
0
5
38
1.32
0.23
1.0
1.0
—
—
—
0
0
24
209
1.15
0.22
1.0
1.1
—
84.6
—
0
8
733
7193
1.02
0.22
1.7
1.6
1.6
1.3
mmol/l
9.33
618
5938
7
95
0.74
0.22
1.6
1.8
25.2
105.2
ug/l
—
7
84
0
10
0.00
0.21
0.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
3.9
—
0
11
31
277
1.12
0.21
1.1
1.1
—
—
—
0
0
206
2137
0.96
0.20
1.3
1.3
—
—
—
0
0
387
3775
1.03
0.19
12.8
7.7
—
—
—
0
0
46
423
1.09
0.19
1.0
1.1
1.5
88.4
iu/ml
1.97
11
77
14
118
1.19
0.19
1.2
1.2
—
—
—
0
0
24
270
0.89
0.19
1.0
1.1
3.0
2.0
u/ml
—
9
109
7
61
1.15
0.17
1.3
1.4
—
—
—
0
0
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
7
62
1.13
0.17
1.4
1.1
77.1
88.8
%
—
7
55
371
3626
1.03
0.17
4.6
4.8
30.6
32.8
%
3.65
259
2371
23
256
0.90
0.16
1.4
1.8
—
—
—
0
0
52
555
0.94
0.15
1.2
1.3
—
—
—
0
0
10
119
0.84
0.15
1.1
1.1
—
—
—
0
0
9
83
1.08
0.14
1.2
2.5
—
—
—
0
0
15
131
1.15
0.14
1.3
1.1
1.0
1.2
u/l
—
8
70
73
766
0.95
0.13
3.0
3.1
0.8
0.8
nmol/l
0.22
55
585
55
581
0.95
0.13
1.1
1.1
5.6
8.9
u/ml
—
5
47
23
252
0.91
0.12
1.1
1.1
18.7
2.6
u/ml
—
5
84
17
152
1.12
0.12
1.2
1.0
—
—
—
0
0
5
44
1.14
0.10
1.0
1.1
—
—
—
0
0
5
45
1.11
0.09
4.6
3.3
46.4
41.9
umol/l
—
5
36
38
360
1.06
0.09
1.7
1.5
77.7
62.3
%
2.47
27
221
496
4906
1.01
0.08
1.2
1.2
1.9
1.8
u/ml
0.03
115
1222
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
5
64
0.78
0.08
1.4
1.4
—
—
—
0
0
393
3976
0.99
0.08
1.3
1.3
41.7
38.1
iu/ml
0.14
117
1226
32
338
0.95
0.08
1.3
1.2
2.3
3.4
u/ml
0.48
12
112
62
599
1.04
0.07
1.1
1.2
3.1
7.9
u/ml
—
9
93
13
118
1.10
0.07
1.5
2.5
111.2
93.3
%
0.68
13
111
54
559
0.97
0.06
1.1
1.1
—
—
—
0
0
8
93
0.86
0.06
1.0
1.2
—
—
—
0
0
76
739
1.03
0.06
1.6
1.6
11558.7
15010.4
e6/l
0.62
58
524
30
315
0.95
0.06
1.1
1.1
—
—
—
0
0
41
425
0.96
0.05
1.2
1.1
56.9
42.1
u/ml
—
8
33
74
723
1.02
0.05
5.1
3.4
7.2
7.7
mmol/l
0.99
74
704
27
282
0.96
0.04
1.4
1.2
7.4
7.6
mmol/l
0.12
20
206
13
121
1.07
0.03
1.8
1.5
9.1
9.9
ug/l
0.11
13
102
30
311
0.96
0.03
1.2
1.5
—
—
—
0
0
12
112
1.07
0.03
1.6
1.3
—
—
—
0
0
16
152
1.05
0.02
1.4
1.6
5.2
7.7
u/l
1.23
11
130
60
591
1.02
0.02
1.1
1.2
2.1
4.1
u/ml
—
6
54
71
717
0.99
0.01
1.7
1.6
—
—
—
0
0
10
94
1.06
0.01
2.2
1.9
14.9
50.3
u/l
—
10
88
19
184
1.03
0.00
3.2
3.7
—
—
—
0
0
76
766
0.99
0.00
5.0
3.3
1.6
1.7
mmol/l
0.18
76
745
58
577
1.01
0.00
1.4
1.4
693.0
901.4
e6/l
0.16
46
474
58
577
1.01
0.00
1.4
1.4
54.9
26.3
e6/l
0.25
46
450
11
108
1.02
0.00
1.2
1.1
—
—
—
0
0
22
220
1.00
0.00
1.0
1.1
—
—
—
0
0
11
110
1.00
0.00
1.2
1.6
86.0
107.0
umol/l
—
5
68
33
325
1.02
0.00
1.2
1.2
3.4
5.3
u/ml
0.62
16
150
56
557
1.01
0.00
1.8
1.9
222.5
203.8
pmol/l
0.63
51
522
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
6
66
0.91
0.00
1.0
1.4
—
—
—
0
0
5
51
0.98
0.00
1.0
1.1
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
7
75
0.93
0.00
1.0
1.1
—
—
—
0
0
6
63
0.95
0.00
1.2
2.1
195.5
214.1
%
—
6
55
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
8
85
0.94
0.00
1.3
2.0
189.9
187.4
%
—
8
76
6
68
0.88
0.00
1.3
1.6
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_KIDNEY_NOTRENALPELVIS – Malignant neoplasm of kidney, except renal pelvis
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).